Liver biopsy in hepatitis C: Reassessing its role in 2001

I.F. Yusoff; L. Mollison; L. Totten; J.K. Olynyk

Back

Liver biopsy in hepatitis C: Reassessing its role in 2001

Journal article

Peer reviewed

Liver biopsy in hepatitis C: Reassessing its role in 2001

I.F. Yusoff, L. Mollison, L. Totten and J.K. Olynyk

Medical Journal of Australia, Vol.176(2), pp.89-90

2002

Files and links (1)

url

Link to Published Version *Subscription may be requiredView

Abstract

To the Editor: Chronic hepatitis C (HCV) infection affects more than 200 000 Australians.1 As the degree of hepatic fibrosis is the best predictor of morbidity, liver biopsy has a central role in management. Biopsy is also carried out to exclude additional pathology.

Details

Title: Liver biopsy in hepatitis C: Reassessing its role in 2001
Authors/Creators: I.F. Yusoff (Author/Creator)
L. Mollison (Author/Creator)
L. Totten (Author/Creator)
J.K. Olynyk (Author/Creator)
Publication Details: Medical Journal of Australia, Vol.176(2), pp.89-90
Publisher: Australasian Medical Publishing Company
Identifiers: 991005544014007891
Murdoch Affiliation: Murdoch University
Language: English
Resource Type: Journal article

Metrics

17 Record Views